Specialized Pro-Resolving Mediators

공액된 테트라엔을 포함하는 삼수산화 지방산

Lipoxin A4 methyl ester (LXA4 methyl ester) is a more lipid soluble, prodrug formulation of the transcellular metabolite LXA4.

Lipoxin B4 (LXB4) is a positional isomer of LXA4 produced by the metabolism of 15-HETE or 15(S)-HpETE by human leukocytes.

Docosahexaenoic acid-d5 (DHA-d5) is intended for use as an internal standard for the quantification of DHA (Item No. 90310) by GC- or LC-MS.

Lipoxin A5 (LXA5) is produced by enzymatic transformation of EPA by leukocytes.

10(S),17(S)-DiHDHA(신경 조직에서 생성될 때 뉴로프로텍틴 D1이라고도 함)는 DHA에서 파생된 디하이드록시 지방산으로 강력한 보호 및 항염 활성을 나타냅니다.

17(S)-HpDHA is a mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, human glial cells, and mouse brain.

7-epi Maresin 1 is the inactive 7(S) epimer of Maresin 1, which contains a 7(R) hydroxyl group.

Maresin 2는 인간 대식세포의 항염증제 및 분해 촉진 매개체입니다.

프로텍틴 D1, 신경 세포에 의해 생성될 때 신경 프로텍틴 D1은 도코사헥사엔산에서 생성되는 새로운 생리 활성 제품 계열의 구성원입니다.

Resolvins are a family of potent lipid mediators derived from both eicosapentaenoic acid and docosahexaenoic acid.

Lipoxin B4 (LXB4) methyl ester is a lipid soluble prodrug form of the transcellular metabolite LXB4.

14(S)-HDHA(14(S)-HDoHE)는 도코사헥사엔산(DHA)의 산소화 생성물입니다.

Resolvins are a group of polyhydroxylated metabolites of docosahexaenoic acid (DHA) found in the inflammatory exudates of aspirin-treated experimental animals.

17(S)-HDHA is a primary mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, and mouse brain.

17(R)-Resolvin D1 (17(R)-RvD1) is an aspirin-triggered epimer of RvD1 that reduces human polymorphonuclear leukocyte transendothelial migration, the earliest event in acute inflammation, with equipotency to RvD1 (EC50 = ~30 nM).

Resolvin D1 메틸 에스테르(RvD1 메틸 에스테르)는 Resolvin D1의 메틸 에스테르입니다.

Resolvin D2 (RvD2) is a lipid mediator biosynthesized by the sequential oxygenation of docosahexaenoic acid by 15- and 5-lipoxygenase.

Resolvin D3 methyl ester is a methyl ester version of the free acid that may act as a lipophilic prodrug form that will alter its distribution and pharmacokinetic properties.

Lipid-derived lipoxins are produced at the site of vascular and mucosal inflammation where they down-regulate polymorphonuclear leukocyte recruitment and function.

The lipoxins are trihydroxy fatty acids containing a 7,9,11,13-conjugated tetraene.

Resolvins are a family of potent lipid mediators derived from both eicosapentaenoic acid and docosahexaenoic acid.

17(R)-Resolvin D4 (17(R)-RvD4) is an aspirin-triggered epimer of RvD4 .

Maresin conjugates in tissue regeneration 1 (MCTR1) is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid in macrophages at the site of inflammation.